Icon partners to create translational research site
Icon has entered into a collaboration with the Central Manchester University Hospitals Foundation (CMFT) to establish a purpose built translational medicine facility in the UK.
Quintiles sets up in Ghana to boost recruitment pool
UK CRO Quintiles Transnational has set up an office in Accra, Ghana in a move it claims allows it to recruit trial participants from sub-Saharan Africa’s estimated 760m residents.
DZS rolls out ClinPlus CTMS for complex trials
US group DZS Software Solutions says its new web ClinPlus CTMS technology will help sponsors and CROs ensure that trial procedures are being followed and eliminate redundant study management systems.
Cogenics rolls out new 1,936 marker DMET screening service
US genomic services specialist Cogenics has launched a new DMET analysis service that it believes will improve patient genotyping during clinical trials, helping drug industry sponsors target the development of new products and reduce costs.
Microsoft adds genomics capacity to Amalga
Microsoft is ramping up its efforts in drug R&D for personalised medicine through the acquisition of genomic analysis technology developed by Seattle, US firm Rosetta Biosoftware.
Merge Healthcare to acquire eTrials after Bio-Imaging bid collapses
IT solutions firm Merge Healthcare has won the race to buy eClinical specialist etrials, beating previous suitor Bio-Imaging Technologies whose takeover bid collapsed on Monday.
MDS sells late stage trial unit to INC Research
Canadian CRO MDS Pharma Services (MDS) is to sell its Phase II-IV trial business to US counterpart INC Research for $50m (€35m) and focus on providing discovery and early clinical development services.
Kendle further expands Asia-Pacific presence
US CRO Kendle has set up three units in Malaysia, Thailand and the Philippines, further demonstrating the growing importance of the Asia Pacific for the contract research sector.
BKK sets up in Japan to combat recruitment lag
US Patient recruitment specialist BBK Worldwide has set up a unit in Osaka, Japan to improve enrolment rates for studies in the country and help local pharma and biotech firms cut costs.
Ockham and etrials team up on EDC
US CRO Ockham Development group will start providing customers with data capture and analysis solutions developed by etrials under a new, five year licensing agreement.
Fate seeks partners to be iPS Catalyst
There has been “tremendous interest” in Fate Therapeutics’ Catalyst programme, which gives access to induced iPS cell technology as part of collaborative relationship between numerous companies.
Patheon aims to be "provider of choice" for cell assays
Canadian contract services group Patheon will roll out a cell based assay offering that it says will help the biopharmaceutical sector advance the development of the next generation of biologic drugs.
UK CRO Quotient Bioresearch has bought a clinical research facility in Edinburgh, Scotland, which in conjunction with an existing unit in Nottingham, England will serve as a base for its new Quotient Clinical unit.
BerGenBio RNAi services attract biotechs
BerGenBio is at BIO 2009 presenting its CellSelectRNAi technology and other services, which in the four months the company has been operational have landed it a multi-million dollar deal with a "big blue-chip pharma".
Global trials call for global ethics, says NEJM study
The increasingly global clinical trial sector demands more effective ethical and regulatory scrutiny according to a study published in the latest edition of the New England Journal of Medicine (NEJM).